Atyr PHARMA (ATYR) Institutional Ownership $3.47 +0.09 (+2.66%) As of 04/30/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Atyr PHARMA (NASDAQ:ATYR)CurrentInstitutional OwnershipPercentage61.72%Number ofInstitutional Buyers(last 12 months)49TotalInstitutional Inflows(last 12 months)$121.54MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$30.20K Get ATYR Insider Trade Alerts Want to know when executives and insiders are buying or selling Atyr PHARMA stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ATYR Institutional Buying and Selling by Quarter Atyr PHARMA Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/28/2025 Cannon Global Investment Management LLC47,500$143K0.3%N/A0.053% 4/21/2025 Kingswood Wealth Advisors LLC37,000$110K0.0%-21.3%0.042% 2/27/2025Jefferies Financial Group Inc.55,600$201K0.0%N/A0.066% 2/18/2025Alpine Global Management LLC17,429$63K0.0%N/A0.021% 2/17/2025Woodline Partners LP1,683,000$6.09M0.0%N/A2.005% 2/17/2025Squarepoint Ops LLC26,614$96K0.0%N/A0.032% 2/17/2025Two Sigma Advisers LP12,250$44K0.0%N/A0.015% 2/17/2025Two Sigma Investments LP21,628$78K0.0%N/A0.026% 2/17/2025Tang Capital Management LLC671,134$2.43M0.2%N/A0.800% 2/17/2025Stempoint Capital LP200,475$726K0.2%N/A0.239% Get the Latest News and Ratings for ATYR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Atyr PHARMA and its competitors with MarketBeat's FREE daily newsletter. 2/17/2025Point72 Asset Management L.P.4,883,197$17.68M0.0%N/A5.817% 2/17/2025Man Group plc15,248$55K0.0%N/A0.018% 2/17/2025OMERS ADMINISTRATION Corp138,000$500K0.0%N/A0.164% 2/17/2025Octagon Capital Advisors LP900,000$3.26M0.5%N/A1.072% 2/17/2025Millennium Management LLC367,989$1.33M0.0%N/A0.438% 2/17/2025Integral Health Asset Management LLC375,000$1.36M0.1%N/A0.447% 2/17/2025J. Goldman & Co LP300,131$1.09M0.0%N/A0.358% 2/17/2025Jefferies Financial Group Inc.55,600$201K0.0%N/A0.066% 2/17/2025Group One Trading LLC7,240$26K0.0%N/A0.009% 2/17/2025Balyasny Asset Management L.P.44,310$160K0.0%N/A0.053% 2/17/2025Bank of America Corp DE91,224$330K0.0%N/A0.109% 2/17/2025Alyeska Investment Group L.P.1,278,441$4.63M0.0%N/A1.523% 2/17/2025Ally Bridge Group NY LLC699,730$2.53M2.1%N/A0.834% 2/17/2025683 Capital Management LLC248,000$898K0.1%N/A0.295% 2/14/2025Jane Street Group LLC199,006$720K0.0%N/A0.237% 2/14/2025Schonfeld Strategic Advisors LLC63,635$230K0.0%N/A0.076% 2/14/2025Northern Trust Corp182,625$661K0.0%N/A0.218% 2/14/2025Oxford Asset Management LLP31,784$115K0.1%N/A0.038% 2/14/2025Boothbay Fund Management LLC14,568$53K0.0%N/A0.017% 2/14/2025Adage Capital Partners GP L.L.C.1,000,000$3.62M0.0%N/A1.191% 2/14/2025Alpine Global Management LLC17,429$63K0.0%N/A0.021% 2/14/2025Tower Research Capital LLC TRC 32,856$119K0.0%N/A0.039% 2/14/2025Dimensional Fund Advisors LP243,369$881K0.0%N/A0.290% 2/13/2025XTX Topco Ltd11,182$40K0.0%N/A0.013% 2/13/2025Barclays PLC159,407$577K0.0%N/A0.190% 2/13/2025Raymond James Financial Inc.10,694$39K0.0%N/A0.013% 2/13/2025Renaissance Technologies LLC574,455$2.08M0.0%N/A0.684% 2/13/2025Federated Hermes Inc.14,666,600$53.09M0.1%N/A17.473% 2/13/2025Tikvah Management LLC2,460,833$8.91M2.5%N/A2.932% 2/13/2025Wells Fargo & Company MN105,769$383K0.0%N/A0.126% Here’s How to Claim Your Stake in Elon’s Private Company, xAI (Ad)I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.All the details are waiting for you now — but you need to act before the May 1st funding window clos2/12/2025ExodusPoint Capital Management LP16,786$61K0.0%N/A0.020% 2/12/2025Knott David M Jr308,133$1.12M0.4%N/A0.367% 2/12/2025Geode Capital Management LLC891,407$3.23M0.0%N/A1.062% 2/12/2025Diametric Capital LP29,812$108K0.1%N/A0.036% 2/12/2025JPMorgan Chase & Co.178,532$646K0.0%+467.8%0.213% 2/11/2025American Century Companies Inc.88,112$319K0.0%N/A0.105% 2/10/2025 Farther Finance Advisors LLC24,423$88K0.0%N/A0.029% 2/6/2025Raymond James Financial Inc.10,694$39K0.0%N/A0.013% 2/6/2025Victory Capital Management Inc.10,138$37K0.0%N/A0.012% 2/6/2025Charles Schwab Investment Management Inc.39,689$144K0.0%N/A0.047% 1/31/2025 D.A. Davidson & CO.39,000$141K0.0%N/A0.046% 1/24/2025 Alterna Wealth Management Inc.10,000$36K0.0%N/A0.012% 1/22/2025 Kingswood Wealth Advisors LLC47,000$170K0.0%N/A0.056% 1/1/2025JPMorgan Chase & Co.31,440$55K0.0%+52.0%0.037% (Data available from 1/1/2016 forward) ATYR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ATYR shares? During the previous two years, 49 institutional investors and hedge funds held shares of Atyr PHARMA. The most heavily invested institutionals were Federated Hermes Inc. ($53.09M), Point72 Asset Management L.P. ($17.68M), Tikvah Management LLC ($8.91M), Woodline Partners LP ($6.09M), Alyeska Investment Group L.P. ($4.63M), Adage Capital Partners GP L.L.C. ($3.62M), and Octagon Capital Advisors LP ($3.26M).Learn more on ATYR's institutional investors. What percentage of Atyr PHARMA stock is owned by institutional investors? 61.72% of Atyr PHARMA stock is owned by institutional investors. Learn more on ATYR's institutional investor holdings. Which institutional investors have been buying Atyr PHARMA stock? Of the 49 institutional investors that purchased Atyr PHARMA stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Federated Hermes Inc. ($14.67M), Point72 Asset Management L.P. ($4.88M), Tikvah Management LLC ($2.46M), Woodline Partners LP ($1.68M), Alyeska Investment Group L.P. ($1.28M), Adage Capital Partners GP L.L.C. ($1M), and Octagon Capital Advisors LP ($900K). How much institutional buying is happening at Atyr PHARMA? Institutional investors have bought a total of 33,586,992 shares in the last 24 months. This purchase volume represents approximately $121.54M in transactions. Which Atyr PHARMA major shareholders have been selling company stock? The following institutional investors have sold Atyr PHARMA stock in the last 24 months: Kingswood Wealth Advisors LLC ($10K). How much institutional selling is happening at Atyr PHARMA? Institutional investors have sold a total of 10,000 shares in the last 24 months. This volume of shares sold represents approximately $30.20K in transactions. Related Companies Amphastar Pharmaceuticals Major Shareholders Ardelyx Major Shareholders Dyne Therapeutics Major Shareholders Aurinia Pharmaceuticals Major Shareholders Syndax Pharmaceuticals Major Shareholders Adaptive Biotechnologies Major Shareholders Iovance Biotherapeutics Major Shareholders Wave Life Sciences Major Shareholders 89bio Major Shareholders Collegium Pharmaceutical Major Shareholders This page (NASDAQ:ATYR) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atyr PHARMA INC Please log in to your account or sign up in order to add this asset to your watchlist. Share Atyr PHARMA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.